全文获取类型
收费全文 | 2443篇 |
免费 | 178篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 160篇 |
妇产科学 | 22篇 |
基础医学 | 313篇 |
口腔科学 | 79篇 |
临床医学 | 247篇 |
内科学 | 491篇 |
皮肤病学 | 43篇 |
神经病学 | 76篇 |
特种医学 | 472篇 |
外科学 | 211篇 |
综合类 | 33篇 |
预防医学 | 121篇 |
眼科学 | 20篇 |
药学 | 137篇 |
中国医学 | 6篇 |
肿瘤学 | 203篇 |
出版年
2021年 | 13篇 |
2020年 | 21篇 |
2019年 | 19篇 |
2018年 | 26篇 |
2017年 | 22篇 |
2016年 | 34篇 |
2015年 | 33篇 |
2014年 | 42篇 |
2013年 | 80篇 |
2012年 | 51篇 |
2011年 | 49篇 |
2010年 | 99篇 |
2009年 | 73篇 |
2008年 | 58篇 |
2007年 | 68篇 |
2006年 | 61篇 |
2005年 | 51篇 |
2004年 | 40篇 |
2003年 | 44篇 |
2002年 | 44篇 |
2001年 | 43篇 |
2000年 | 48篇 |
1999年 | 45篇 |
1998年 | 143篇 |
1997年 | 126篇 |
1996年 | 141篇 |
1995年 | 103篇 |
1994年 | 82篇 |
1993年 | 87篇 |
1992年 | 39篇 |
1991年 | 41篇 |
1990年 | 27篇 |
1989年 | 87篇 |
1988年 | 59篇 |
1987年 | 64篇 |
1986年 | 65篇 |
1985年 | 63篇 |
1984年 | 38篇 |
1983年 | 46篇 |
1982年 | 44篇 |
1981年 | 24篇 |
1980年 | 42篇 |
1979年 | 24篇 |
1978年 | 28篇 |
1977年 | 26篇 |
1976年 | 30篇 |
1975年 | 31篇 |
1974年 | 10篇 |
1973年 | 13篇 |
1969年 | 16篇 |
排序方式: 共有2644条查询结果,搜索用时 15 毫秒
1.
H. D. Tagare K. W. Elder D. M. Stoner R. M. Patterson C. L. Nicodemus S. F. Viegas Dr. G. R. Hillman 《Annals of biomedical engineering》1993,21(6):715-726
The carpal regions of ten cadaver extremities were imaged by CT. The images were combined into a 3-dimensional model of the
carpus using a technique based on a dynamic programming algorithm to find an optimal estimate of the location of the bone
boundaries in the CT images. The resulting set of surface points on each bone was used to compute volumes and principal and
antipodal axes for the bones. A spatial coordinate system was established based on the positions of the centroids of three
bones in the distal carpal row. The angular orientations of all carpal bones were determined with respect to this system.
The principal axes for the same bone among ten wrist specimens proved to be more widely dispersed than the antipodal axes
for the same bones. The antipodal axes also correspond more closely to an intuitive notion of the “longest axis” of the bones.
We conclude that the antipodal axis is a more reliable and useful measure of bone orientation than the principal axis. 相似文献
2.
Scott S Auerbach Joshua G Dekeyser Matthew A Stoner Curtis J Omiecinski 《Drug metabolism and disposition》2007,35(3):428-439
The constitutive androstane receptor (CAR; NR1I3) regulates the expression of genes involved in xenobiotic metabolism. Alternative splicing of the human CAR gene yields an array of mRNAs that encode structurally diverse proteins. One form of CAR, termed CAR2, contains an additional four amino acids (SPTV) that are predicted to reshape the ligand-binding pocket. The current studies show a marked, ligand-independent, CAR2-mediated transactivation of reporters containing optimal DR-3, DR-4, and DR-5 response elements, and reporters derived from the natural CYP2B6 and CYP3A4 gene promoters. Overexpression of the RXRalpha ligand binding domain was critical for achieving these effects. CAR2 interaction with SRC-1 was similarly dependent on the coexpression of RXRalpha. Mutagenesis of Ser233 (SPTV) to an alanine residue yielded a receptor possessing higher constitutive activity. Alternatively, mutating Ser233 to an aspartate residue drastically reduced the transactivation capacity of CAR2. The respective abilities of these mutagenized forms of CAR2 to transactivate a DR-4 x 3 reporter element correlated with their ability to interact with RxRalpha and to recruit SRC-1 in a ligand-regulated manner. Together, these results demonstrate a robust RXRalpha-dependent recruitment of coactivators and transactivation by CAR2. In addition, CAR2 displays novel dose responses to clotrimazole and androstanol compared with the reference form of the receptor while at the same time retaining the ability to bind CITCO. This result supports a hypothesis whereby the four-amino-acid insertion in CAR2 structurally modifies its ligand binding pocket, suggesting that CAR2 is regulated by a set of ligands distinct from those governing the activity of reference CAR. 相似文献
3.
Extended-release divalproex in bipolar and other psychiatric disorders: A comprehensive review
下载免费PDF全文
![点击此处可从《Neuropsychiatric Disease and Treatment》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Bipolar disorder can be a devastating disease state for individuals with the disease and also for family members. Proper recognition and treatment is vital to the successful management of this disease state. Through increased community and practitioner awareness, along with efforts to increase awareness for proper assessment, the rate of diagnosed bipolar disorder is increasing. Recent years have brought about the introduction of several new medications with approved indications for the treatment of bipolar disorder. In addition to new agents, traditional mood stabilizing medications have also been released in different formulations to better enhance tolerability without jeopardizing efficacy. One particular product is extended-release divalproex sodium. In the following article, we review the clinical presentation of bipolar disorder, its epidemiology, and the pharmacokinetics and mechanism of action for divalproex. In addition, we specifically review the role of extended-release divalproex in bipolar disorder through a critical analysis of the currently available published primary literature. 相似文献
4.
JA HYEON KU CHEOL KWAK SEUNG-JUNE OH EUNSIK LEE SANG EUN LEE JAE-SEUNG PAICK 《International journal of urology》2004,11(7):489-493
BACKGROUND: Our aims in the present study were to estimate the influences of pain and urinary symptoms on quality of life, and to determine which of these two variables has the most predictive power with respect to quality of life in young men with chronic prostatitis-like symptoms. METHODS: Chronic prostatitis-like symptoms were measured by the National Institutes of Health-Chronic Prostatitis Symptom Index. Of the 28,841 men aged 20 years who lived in the study community, 18,495 men (a response rate 64.1%) agreed to participate in the study. A total of 1057 men who complained of symptoms indicative of chronic prostatitis were included in the study. The influences of pain and urinary symptoms on quality of life were determined using logistic regression analysis. The receiver operating characteristic (ROC) curve was used to estimate the predictive ability of each of these variables with respect to quality of life. RESULTS: Results from multivariate analysis showed that both pain and urinary symptoms were associated with an increased likelihood of impaired quality of life, although pain contributed more to a reduced quality of life than urinary symptoms. Relative to men who experienced mild pain, men who experienced moderate pain had a 3.9-fold risk of poor quality of life (odds ratio [OR], 3.87; 95% confidence interval [CI], 2.86-5.23; P < 0.001) and those who experienced severe pain had a 15.7-fold risk of reduced quality of life (OR, 15.68; 95% CI, 6.59-37.35; P < 0.001). Moderate urinary symptoms were associated with a 1.4-fold risk of bother (OR, 1.41; 95% CI, 1.01-1.99; P < 0.001) and severe urinary symptoms were associated with 2.4-fold risk (OR, 2.39; 95% CI, 1.37-4.12; P < 0.001), relative to mild urinary symptoms. Comparison of the effects of pain and urinary symptoms showed that pain severity had the most predictive power for bother, quality of life, and quality-of-life impact. The areas under the ROC curves for bother, quality of life, and quality-of-life impact were 71.3%, 69.3% and 72.5%, respectively. CONCLUSION: Urinary symptoms and pain might be associated with an increased likelihood of impaired quality of life in young men with chronic prostatitis-like symptoms. In addition, our findings suggest that pain severity is the most influential variable for determining quality of life in this population. 相似文献
5.
Daniel A. Monti Marie E. Stoner Gail Zivin Martha Schlesinger 《Journal of cancer survivorship》2007,1(2):161-166
Introduction As many as one quarter of all cancer survivors report traumatic stress symptoms from cancer-related experiences. While the
majority of these patients do not meet the criteria for posttraumatic stress disorder (PTSD), there is growing evidence that
subsyndromal symptoms can significantly contribute to functional impairment and negative health outcomes. Treatment options
for the hallmark symptoms of traumatic stress—unpleasant, intrusive thoughts and avoidant behaviors—have not been well investigated
for the cancer survivorship population.
Materials and methods Seven female cancer survivors with traumatic stress symptoms from cancer-related experiences and no other major psychopathology,
were enrolled to receive three sessions of Neuro-Emotional Technique (NET), a brief, targeted treatment that combines traditional
desensitization principles with complementary modalities.
Results Psychological outcome measures (Impact of Event Scale (IES) and Subjective Units of Distress (SUD) and physiological measures
(Heart Rate (HR) and Skin Conductance Level (SCL) demonstrated the following changes: 71% on IES, 88% SUD, 74% on HR, and
65% on SCL following the intervention. Statistically significant changes were observed for all four parameters, and effect
size g for proportion improved were 0.50 each for IES, SUD, and HR, and 0.20 for SCL.
Conclusions These cases suggest feasibility of the NET intervention for cancer-related traumatic stress and the potential for change in
symptoms and physiological reactivity. Further investigation is needed to determine the specific and long-term effects of
such an approach.
Implications for cancer survivors Traumatic stress from cancer-related experiences might represent a constellation of symptoms that are amenable to brief, targeted
interventions.
This study was supported by the O.N.E. Research Foundation 相似文献
6.
7.
Cyclosporine A inhibition of microcystin toxins 总被引:2,自引:0,他引:2
Cyclosporine A (CyA) given i.v. at a dose of 1.25 mg/mouse blocks a subsequent i.v. lethal dose (1.7-1.8 x LD50) of microcystin-LR for 24 hr, and is about 50% protective at 48 hr. Conversely, the fraction of mice that can be rescued by CyA (0.2 mg/mouse) after a lethal dose of microcystin-LR decreases rapidly with a pharmacodynamic half-time of only about 100 sec. The prophylactic action of CyA was tested against lethal doses of four microcystins. The acute lethality of 1.7-1.8 x LD50 dose of microcystin-LR, -RR, -LY, or -LA given 1 hr after administration of 0.2 mg of CyA is 0%, 0%, 58%, or 100%, respectively. Even a 0.6 mg/mouse dose of CyA is ineffective prophylaxis against a lethal dose of microcystin-LA. The inhibitory potency of CyA on microcystin toxicity can be completely reversed by the single L-amino acid substitution of alanine for arginine in the microcystin. 相似文献
8.
9.
10.